The company
Petco Health and Wellness Company, Inc.
WOOF · Nasdaq
WOOF stood above a rising 150-day average in 1 of the last 52 weekly readings, and has been out of that trend for the last 51 weeks. It is 13.3% below that average now. Retail — Specialty: 27% of its 106 stocks in an uptrend (+2 points in four weeks); Consumer Discretionary: 26% (+2 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 51
- Industry in uptrend
- 27% +2 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $3.2M
- Officials’ trades on record
- 22
- Institutions holding
- 184 (-7)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 1 of 52 weeks.
Retail — Specialty: A minority of its stocks are in an uptrend and the share has held steady. Consumer Discretionary: A minority of its stocks are in an uptrend and the share has held steady.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
22 disclosed lines: House 4, Senate 18, executive 0; 2 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| James B. Renacci House: U.S. House ClerkOH16 | sold | $1k–$15k | 27 Mar 2017filed 4 Apr 2017 |
| David Perdue Senate: U.S. Senate eFDSenator | soldjoint | $1k–$15k | 14 Mar 2017filed 31 Mar 2017 |
| David Perdue Senate: U.S. Senate eFDSenator | sold part ofjoint | $1k–$15k | 1 Mar 2017filed 31 Mar 2017 |
| David Perdue Senate: U.S. Senate eFDSenator | sold part ofjoint | $15k–$50k | 23 Feb 2017filed 5 Jul 2018 |
| David Perdue Senate: U.S. Senate eFDSenator | sold part ofjoint | $15k–$50k | 23 Feb 2017filed 1 Mar 2017 |
| David Perdue Senate: U.S. Senate eFDSenator | sold part ofjoint | $1k–$15k | 10 Feb 2017filed 5 Jul 2018 |
| David Perdue Senate: U.S. Senate eFDSenator | sold part ofjoint | $1k–$15k | 10 Feb 2017filed 1 Mar 2017 |
| James B. Renacci House: U.S. House ClerkOH16 | sold | $1k–$15k | 10 Feb 2017filed 22 Feb 2017 |
| David Perdue Senate: U.S. Senate eFDSenator | sold part ofjoint | $1k–$15k | 9 Feb 2017filed 5 Jul 2018 |
| David Perdue Senate: U.S. Senate eFDSenator | sold part ofjoint | $1k–$15k | 9 Feb 2017filed 1 Mar 2017 |
| David Perdue Senate: U.S. Senate eFDSenator | sold part ofjoint | $1k–$15k | 6 Feb 2017filed 5 Jul 2018 |
| David Perdue Senate: U.S. Senate eFDSenator | sold part ofjoint | $1k–$15k | 6 Feb 2017filed 1 Mar 2017 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Holly MayChief Human Resources Officer | sold | 200,000at $2.54 | 9 Jul 2026filed 10 Jul 2026 |
| Holly MayChief Human Resources Officer | sold | 150,000at $2.55 | 8 Jul 2026filed 9 Jul 2026 |
| Holly MayChief Human Resources Officer | sold | 100,000at $2.55 | 7 Jul 2026filed 9 Jul 2026 |
| Patrick J. VeneziaChief Revenue Officer | sold | 102,029at $3.42 | 13 Mar 2026filed 17 Mar 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| CVC Management Holdings II Ltd.unchanged · filed 14 Aug 2026 | 145,924,140$396.9M | 00.0% |
| CANADA PENSION PLAN INVESTMENT BOARDunchanged · filed 14 Aug 2026 | 59,765,368$162.6M | 00.0% |
| DIMENSIONAL FUND ADVISORS LPadded · filed 11 Aug 2026 | 11,072,709$30.1M | +961,648+9.5% |
| Long Focus Capital Management, LLCadded · filed 14 Aug 2026 | 8,371,050$22.8M | +360,999+4.5% |
| BlackRock, Inc.reduced · filed 7 Aug 2026 | 8,082,129$22.0M | -131,866−1.6% |
| TWO SIGMA INVESTMENTS, LPreduced · filed 14 Aug 2026 | 5,577,176$15.2M | -392,398−6.6% |
| Holocene Advisors, LPreduced · filed 14 Aug 2026 | 4,904,000$13.3M | -858,654−14.9% |
| Cresset Asset Management, LLCunchanged · filed 14 Aug 2026 | 3,865,368$10.5M | 00.0% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 3,842,365$10.5M | +359,013+10.3% |
| FMR LLCreduced · filed 13 Aug 2026 | 3,822,806$10.4M | -316,175−7.6% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.